Abstract. Reversible splenial lesion syndrome (RESLES) is a rare clinico-radiological syndrome that is defined as reversible lesions that involve the splenium of the corpus callosum (SCC). RESLES has been reported in patients with a broad spectrum of diseases and conditions, including infections, hypoglycemia and poisoning. The present report described four RESLES cases triggered by Mycoplasma pneumoniae (M. pneumoniae) and discussed the associated diagnostic challenges. Four cases of acute M. pneumoniae-associated encephalitis that displayed RESLES were reviewed. The clinical presentations were nonspecific in these patients. However, magnetic resonance imaging (MRI) revealed consistent lesions in the SCC with a hyperintensity in diffusion-weighted imaging (DWI) and hypointensities in T1WI, which disappeared after a variable lapse. Treatment with azithromycin or combined treatment with immunomodulatory agents if necessary led to a good prognosis. The present findings indicated that radiological diagnosis of RESLES should be considered in patients with M. pneumoniaeassociated encephalitis. Furthermore, serum Mycoplasma antibody is important for the diagnosis of M. pneumoniae-associated encephalitis.
Introduction
Mycoplasma pneumoniae (M. pneumoniae) is a common respiratory tract pathogen, especially in children (1) (2) (3) . Up to 40% of cases of community-acquired pneumoniae admitted to the hospital are due to M. pneumoniae infection. The central nervous system (CNS) may be one of the most susceptible sites of M. pneumoniae besides the respiratory system (4) . M. pneumoniae infection accounts for 5-10% of pediatric encephalitis patients and up to 60% of these patients show neurologic sequelae and neuroimaging discloses normal findings or focal diffuse edema (5) . There have been few reports of the clinical characteristics of adult M. pneumoniae-associated encephalitis and the use of magnetic resonance imaging (MRI) in the diagnosis.
Reversible splenial lesion syndrome (RESLES) is a rare clinico-radiological syndrome that is defined as reversible lesions that involve the splenium of the corpus callosum (SCC). RESLES has been reported in patients with a broad spectrum of diseases and conditions, including infections, hypoglycemia, and poisoning. However, the pathophysiological mechanism of RESLES is not well known (6) .
We report four cases of adult mycoplasma-associated encephalitis in which MRI scan revealed reversible lesions in RESLES. Complete recovery of clinical symptoms and signs were observed in a few days or weeks after treatment.
Is a common respiratory tract pathogen, especially in children (1) (2) (3) . Up to 40% of cases of community-acquired pneumoniae admitted to the hospital are due to M. pneumoniae infection. The CNS may be one of the most susceptible sites of M. pneumoniae besides the respiratory system (4) . M. pneumoniae infection accounts for 5-10% of pediatric encephalitis patients and up to 60% of these patients show neurologic sequelae and neuroimaging discloses normal findings or focal diffuse edema (5) . There have been few reports of the clinical characteristics of adult M. pneumoniae-associated encephalitis and the use of MRI in the diagnosis. RESLES is a rare clinico-radiological syndrome that is defined as reversible lesions that involve the SCC. RESLES has been reported in patients with a broad spectrum of diseases and conditions, including infections, hypoglycemia, and poisoning. However, the pathophysiological mechanism of RESLES is not well known (6) .
and MRI scans were completed in the days after admission. The two male and two female patients in this retrospective study had an average age of 29.5±11.0 years. None of the patients had suffered from brain trauma, toxic or metabolic encephalitis/encephalopathy, cerebral vascular diseases, and cerebral neoplasma.
MRI was performed using 3.0 T units that comprised axes of T1-and T2-weighted sequences. Fast fluid attenuated inversion recovery (FLAIR) sequences and diffusion-weighted imaging (DWI) were performed using an axial multi-section single-shot echo-planar SE sequence. Enhanced T1-weighted scans obtained after intravenous administration of 10 ml of gadoteric acid 0.5 mmol/ml. MRI findings, such as the shape of the splenial lesion, and the DWI and FLAIR findings were evaluated by two neuroimaging specialists with over 10 years experience each. For M. pneumoniae serology detection, IgM and IgG antibodies were detected using the SeroMP IgM and IgG kit (Tecan Group, Ltd., Mannedorf, Switzerland), which is a semi-quantitative ELISA to determine the antibodies specific to M. pneumoniae. The antigen used in the SeroMP kit is the P1 membrane protein, which is the most important virulence factor of M. pneumoniae (7) . Based on the manufacturer's suggestion, a positive IgM as ≥1.1S/CO, the quantitative IgG was also detected between 7 to 14 days after the first test, while recording the multiplier of the increase of IgG (IgG ≥22 RU/ml as positive). An IgM positive reaction together with an increase of IgG exceeding 4 times in patients indicated the presence of M. pneumoniae acute infection (8) . Other laboratory tests including biochemical and microbiological examinations of the CSF were available in all cases. After treatment with azithromycin, the clinical symptoms and signs recovered quickly. A follow-up MRI showed all lesions in SCC were reversible at 10, 24, 12, and 7 days in case 1, 2, 3, and 4, respectively.
Description of cases Case 1.
A 31-year-old Chinese man was transferred to our emergency room from a nearby primary hospital. He had developed a cold and a fever 3 days previously. His body temperature reached 39˚C. He had persistent headaches. After 2 days' treatment in the primary hospital, the fever and headache were not improved. At admission, we found he had mild somnolence and Kernig sign (+), with other neurological examinations being negative. Chest computed tomography (CT) revealed an infective lesion in the right lung lobe. In the third day following administration, a cranial MRI scan showed focal hyper-intensities signals on the DWI, T2, and FLAIR sequences and hypo-intensities on the T1 sequence in SCC (Fig. 1) . Routine blood laboratory examination revealed no obvious abnormalities. Serum M. pneumoniae antibody showed IgM positive, with an IgG titer elevated to 1:80. Serologic and pathogenic detection for other pathogens including Chlamydia pneumoniae, varicella zoster virus (VZV), mumps virus, measles virus, herpes simplex virus (HSV) 1 and 2, cytomegalovirus (CMV) and Japanese encephalitis virus (JEV) were negative. CSF analysis showed a high pressure (200 mmH 2 O), a normal total white cell count of 6x10 6 /l (reference range 0-5x10 6 /l), CSF protein of 0.25 g/l (reference range 0.15-0.45 g/l), glucose of 4.14 mmol/l (reference range 2.5-4.5 mmol), and chloride of 120.6 mmol/l (reference range 120-132 mmol/l). General bacteria, tubercle bacilli, and cryptococcus were not detected. Considering the clinical and serological results together with the radiological findings, acute encephalitis due to M. pneumoniae infection was diagnosed. Patient was treated with intravenous azithromycin (10 mg/kg/day) for 2 weeks. The body temperature returned to normal 3 days later during hospitalization. The headache improved significantly after 6 days. Cranial MRI scan performed at day 10 following admission showed the complete disappearance of focal hyperintersities in SCC (Fig. 2) . The serum M. pneumoniae antibody IgG was retested at day 12; an elevated titer of 1:1,280 was evident. The results confirmed the diagnosis of M. pneumoniae encephalitis.
Case 2.
A week prior to admission, a 33-year-old Chinese woman developed headache and fever without obvious predisposing causes. The highest body temperature was 37.8˚C. Four days later, the patient developed blurred vision and a paroxysmal amaurosis. A brain CT at that time performed at the fourth hospital affiliated to China medical university revealed no abnormalities. Specific serum M. pneumoniae antibody was markedly elevated to 1:320 on day 6 after onset. CSF analysis was abnormal with a pressure of 290 mmH 2 O, 316x10 6 /l white cells, and 1.32 g/l protein. Other laboratory tests of CFS, including general bacteria, tubercle bacilli, and cryptococcus were all negative. At that time, the patient was treated with mannitol (250 ml every 8 h), ganciclovir (50 mg/kg/day with treatment every 12 h) and azithromycin (10 mg/kg/day). Symptoms did not improve. The patient displayed nausea and vomiting, and body temperature reached 39.5˚C. The patient was transferred to our hospital on day 9. The patient had no past history of other related diseases except gastric ulcer and hypertension. Neurological examination on administration showed poor mental status and drowsiness, limb muscle strength grade 4, and neck rigidity (+). Other neurological signs were negative. Laboratory examination showed specific serum M. pneumoniae antibody (IgM) was positive and IgG antibody titer was elevated to 1:640. Serology for other pathogens including C. pneumoniae, VZV, mumps virus, measles virus, HSV 1 and 2, CMV, and JEV were negative. CSF analysis showed a pressure of 350 mmH 2 O, Pandy reaction (+), an abnormal white cell count of 286x10 6 /l, monocyte percentage 96.9%, protein 0.96 g/l, 2.46 mmol/l glucose, and 119.7 mmol/l chloride. Chest CT scan showed infective lesions in the middle lobe of the right lung and the upper lobe of the left lung. Brain enhanced MRI showed focal high-signal lesion in the SCC on DWI, indicating a cytotoxic edema (Fig. 3) . The clinical and serological results together with the radiological findings lead to a diagnosis of acute encephalitis due to M. pneumoniae infection and intrapulmonary infection. Azithromycin (10 mg/kg/day) was administered for 10 days. Mannitol (250 ml every 8 h) was given to reduce intracranial pressure. Methylprednisolone (20 mg/kg/day) for a week, and immunoglobulin (0.4 g/kg/day) were also given for 5 days for immunoregulation and to inhibit the inflammatory response. The symptoms improved significantly. Ten days after admission, the patient no longer had headache and fever. (Fig. 4) .
Case 3.
A 40-year-old man was admitted to the hospital from a nearby primary hospital with headache and fever for more than 10 days that occurred after overworking and becoming chilled. The highest body temperature of the patient was 38.9˚C. The patient went to a nearby hospital when his vision blurred. At that time, mannitol, ganciclovir, and ceftriaxone were given for treatment (the detailed dosages are unknown). The headache did not improve and he became disoriented. The patient was transferred to our hospital. cell count (86x10 6 /l), monocyte percentage of 98.7%, protein 2.83 g/l, glucose 2.24 mmol/l, and chloride 122.6 mmol/l. General bacteria, tubercle bacilli, and cryptococcus were not detected. The clinical and serological results (especially elevated serum M. pneumoniae antibody titer) together with the radiological findings supported a diagnosis of acute Mycoplasma encephalitis. Azithromycin (10 mg/kg/day) was administrated for treatment, while mannitol (250 ml every 8 h) was given to reduce intracranial pressure. The treatment was effective. On the seventh day after admission, the headache and blurred vision had significantly improved. Fever remained intermittent and the body temperature reached 37.5˚C. On day 14 after admission, body temperature had returned to normal and M. pneumoniae antibody titer determined on 2015-05-31 had markedly declined to 1:160. A follow-up brain MRI scan on 2015-06-02 did not show obvious anomalies (Fig. 6) .
Case 4. A 14-year-old female patient was transferred to our hospital due to fever and headache for one week, accompanied with vomiting twice. Physical examination showed a body temperature of 38.8˚C. Neurological examination found neck rigidity (+). Other neurological examinations were normal. Chest CT scan done on 2016-11-21 revealed some inflammation in the upper segment of the inferior lobe of the right lung and frontier segment of the superior lobe of the left lung. Cranial MRI done on 2016-11-22 showed focal hyper-intensities signal on the T2, DWI, FLAIR sequence, and hypo-intensities on the T1 sequence in SCC (Fig. 7) . Laboratory examination showed M. pneumoniae IgM antibody positive, and the IgG titer was 1:160. Serology for other pathogens including C. pneumoniae, VZV, mumps virus, measles virus, HSV 1 and 2, CMV and JEV were negative. CSF analysis showed a pressure of 200 mmH 2 O, an General bacteria, tubercle bacilli, and cryptococcus were not detected. The combined clinical and serological results together with the radiological findings supported a diagnosed as acute Mycoplasma encephalitis. The patient was treated with intravenous azithromycin (10 mg/kg/day) for 2 weeks. The symptoms improved significantly at the sixth day after admission. At that time the headache and vomiting had ended, and she had normal body temperature. Two weeks after treatment, neurological examination showed Kernig sign (-), neck rigidity (-), and other neurological examinations were all negative. Re-examination of the cranial MRI on 2016-11-28 showed that the high signal of SCC had decreased (Fig. 8) . Re-examination of CSF analysis on 2016-12-06 showed a pressure of 150 mmH 2 O, abnormal white cell count (50x10 6 /l), 98% monocytes, Pandy reaction (+), protein 0.78 g/l, and normal glucose and chloride.
Discussion
Adult CNS involvement associated with M. pneumoniae infection is being reported with increasing frequency (9,10), but the diagnostic criteria, clinical manifestations, and cranial imaging changes of M. pneumoniae encephalitis are still not elucidated. In this case series, we observed four clinically confirmed M. pneumoniae encephalitis patients, all of whom had transient SCC lesions in cranial MRI. Through the review of this series of cases, we hope to help clinicians to get a better understanding of M. pneumoniae encephalitis.
Despite advances in diagnostic techniques, the diagnosis of M. pneumoniae encephalitis is still challenging. Although depending on the serological testing for diagnosis of M. pneumoniae encephalitis may be problematic, it is undeniable that serological testing is the mainstay for diagnosis of M. pneumoniae infection, especially in developing countries where PCR technology and Western blot are not readily available. Additionally, serological test saves more time than Mycoplasma culture, and may reach a similar sensitivity as PCR for diagnosis of acute infection of M. pneumoniae (11, 12) . In our study, one of our diagnostic staples was the detection of serum antibody. Specific IgM antibody to M. pneumoniae in an acute infectious phase responses usually in the first 7-10 days of illness and precedes IgG response by a few days (13) . A four-fold increase in titer between acute and convalescent sera of IgG is also important to patients' diagnosis. In our cases, all four adult patients have 4-fold increase in IgG, confirming the M. pneumoniae infection (14) .
CNS disorders, such as encephalitis, meningitis, cerebellitis, and myelitis, are common extrapulmonary manifestations of M. pneumoniae infection (15) . One of the most common clinical manifestations of M. pneumoniae encephalitis in adults is encephalopathy. Symptoms may range from a subtle effect on mental status with personality and behavioral changes to stupor and coma (16) . Other frequently reported manifestations include epileptic activity, meningeal signs (i.e., headache, neck stiffness, vomiting) and ataxia. Focal neurological deficits may be observed as well (8, 17, 18) . In the present study, all patients had fever and headache, three of four had neck stiffness, two had disturbance of consciousness, and one patient had visual disturbance, which was consistent with previous reports.
The MRI findings of M. pneumoniae-associated encephalitis are quite variable and haphazard. It is more sensitive than CT in the detection of subtle lesions even in the early stage of infection (19) . However, the proportion of imaging abnormalities is still unclear (20) . The involved regions include the cerebral cortex, hemisphere, basal ganglia, hippocampus, cerebellum, and corpus callosum (21) . We observed reversible focal lesions in the SCC in all four patients, which has been reported and defined as RESLES in hypoglycemia, hypernatremia, high-altitude cerebral edema or antiepileptic drug toxicity or withdrawal (6), but has rarely been reported in acute M. pneumoniae-associated encephalitis. We reported the largest number of acute M. pneumoniae-associated encephalitis with RESLES to date. The pathophysiological mechanisms of M. pneumoniae-associated encephalitis, especially selective splenial lesions in the SCC, are not very clear. It has been proposed that the specific affinity of infective/auto-immunological antigens or induced antibodies to the splenial axonal receptors are responsible for the splenial involvement in infective/auto-immunological encephalitis (22, 23) . Moreover, it has been postulated that the SCC results in specific vulnerability to excitotoxicity injury in metabolic diseases, which makes this area selectively involved in different pathological events (24) . Besides these two possible mechanisms, direct infection of the brain could be another underlying mechanism for post infectious complications of M. pneumoniae infection, but it is incapable of explaining the solitary involvement of the SCC (16) . Therefore, we speculate that autoimmune-mediated brain injury may be a possible reason. In this scenario, M. pneumoniae-derived antigenic elements could bound to blood macrophages or monocytes may initiate complex immune reactions (25) . The CSF analyses of our cases showed the clearly increased percentage of monocytes, which might be related with immune complex formation and could further lead to subsequent neurological damage (16) . Other disorders that could lead to RESLES include viral encephalitis, antiepileptic drug toxicity or withdrawal, hypoglycemia, and autoimmune encephalopathy/encephalitis (6) . All of the aforementioned disorders could be excluded in the four patients described in this study. The role of antibiotic in the treatment of M. pneumoniae associated encephalitis remains unresolved because of the lack of controlled trials (2, 26) . Several therapeutic measures including antibiotics, corticosteroids, intravenous immunoglobulin and plasmapheresis have been reported for treatment of M. pneumoniae-associated encephalitis (27) (28) (29) . The macrolides are considered the first-line agents for M. pneumoniae infections, although such antibiotics may poorly traverse the blood-brain barrier (30) . Despite lack of the available literature data that may help to provide guidance regarding the efficacy of antibiotic therapies, azithromycin was administrated to treat our patients and good curative effects were obtained. As the possible immunological origin of M. pneumoniae-associated encephalitis, immunomodulatory treatment may help (31) . One of our patients received corticosteroids combined with intravenous immunoglobulin; good prognosis was obtained in both the respiratory and nervous systems.
In this case series, four cases with the involvement of splenium due to M. pneumoniae infection are described. All cases received azithromycin treatment alone or combined with immunomodulatory treatment. All of the patients made a full recovery and we found reversible signal changes in MRI findings in the corpus callosum lesions during the follow-up periods. Further studies should be performed to clarify the possible mechanisms underlying CNS involvement due to M. pneumoniae infection and controlled trials should be conducted to assess the effectiveness of therapeutic methods.
